Chemed Corporation reiterates earnings guidance for full year 2024. For the full year, company reiterates earnings per diluted share, excluding: non-cash expense for stock options, tax benefits from stock option exercises, costs related to litigation, and other discrete items, guidance range of $23.30 to $23.70.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
541.3 USD | -0.22% |
|
+0.41% | -7.44% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.44% | 8.16B | |
+26.12% | 89.41B | |
-21.82% | 77.49B | |
+2.39% | 27.13B | |
-8.49% | 17.53B | |
+1.07% | 17.14B | |
+1.70% | 15.58B | |
-25.79% | 12.92B | |
+71.47% | 13.19B | |
+80.01% | 13.29B |
- Stock Market
- Equities
- CHE Stock
- News Chemed Corporation
- Chemed Corporation Reiterates Earnings Guidance for Full Year 2024